• About us
• Contact

Advertisement

Organisation › Details

Fluidigm (Group)

Fluidigm (Nasdaq:FLDM) focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, we develop, manufacture, and market multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Our customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, we strive to increase the quality of life for all. *

 

	Start	2001-07-02 existent
	End	2022-04-04 renamed
	Group	Standard BioTools (Group)
	Today	Standard BioTools (Group)
	Predecessor	Mycometrix
	Successor	Standard BioTools (Group)
	Industry	microfluidics technology
	Industry 2	microfluidics product (BCC)
	Person	Linthwaite, S. Christopher (Chris) (Fluidigm 201610– CEO joined 201608 as COO before Thermo Fisher + Life Technologies)
	Person 2	Jog, Vikram (Fluidigm 200802– CFO before XDx CFO + Applera)
	Region	South San Francisco, CA
	Country	United States (USA)
	Street	7000 Shoreline Court Suite 100
	City	94080 South San Francisco, CA
	Tel	+1-650-266-6000
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
	Currency	USD
	Annual sales	117,243,000 (revenue, total, consolidated (2019) 2019-12-31)
	Profit	-64,790,000 (2019-12-31)
	Cash	49,600,000 (2020-03-31)
		* Document for »About Section«: Fluidigm Corporation. (4/1/22). "Press Release: Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion". South San Francisco, CA.
		Record changed: 2024-08-12

Advertisement

More documents for Standard BioTools (Group)

• [1] Standard BioTools Inc.. (8/6/24). "Press Release: Standard BioTools to Participate in Upcoming Investor Conferences". South San Francisco, CA....
• [2] Standard BioTools Inc.. (1/5/24). "Press Release: Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools". South San Francisco, CA & Boulder, CO....
• [3] Standard BioTools Inc.. (10/4/23). "Press Release: Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools". South San Francisco, CA & Boulder, CO....
• [4] Fluidigm Corporation. (4/4/22). "Press Release: Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.". South San Francisco, CA....
• [5] Fluidigm Corporation. (4/1/22). "Press Release: Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion". South San Francisco, CA....
• [6] Fluidigm Corporation. (3/28/22). "Press Release: Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution". South San Francisco, CA....
• [7] Fluidigm Corporation. (1/24/22). "Press Release: Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.". South San Francisco, CA....
• [8] SomaLogic, Inc.. (12/2/21). "Press Release: SomaLogic Announces Appointment of Steven Mermelstein as Senior Vice President of Corporate Strategy, Development and Mergers and Acquisitions". Boulder, CO....
• [9] Fluidigm Corporation. (9/2/21). "Press Release: Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference". South San Francisco, CA....
• [10] SomaLogic, Inc.. (12/22/20). "Press Release: SomaLogic Adds $81M to Series A Financing Totaling $214M". Boulder, CO....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.